Affiliation:
1. Department of Chemical Engineering, Hamadan University of Technology, Hamadan, Iran
2. Department of Mining Engineering, Technical University of Hamadan, Hamadan, Iran
Abstract
Background: The objective of the present study was to design a porous osmotic pump-based drug delivery system for the controlled release of captopril (Cap) which can maintain a constant therapeutic concentration, thus reducing dose-related side effects and dosing frequency. Methods: The study evaluated in vitro drug release for the controlled porosity osmotic pump tablet (CPOPT) of Cap. This in vitro drug release study investigated the influence of the tablet formulation variables such as the amount of mannitol, hydroxypropylmethylcellulose K4M (HPMCK4M), and polyvinyl pyrrolidone (PVP K-30) in the core and the concentration of cellulose acetate and polyethylene glycol 400 (PEG-400) in the coating solution. Results: It was found that the drug release was mostly affected by the amount of mannitol, HPMCK4M, and PVP K-30 in the core and the amount of cellulose acetate and PEG-400 in the coating solution. Conclusion: In general, the objective of the study was established by coating the core tablet containing osmotic and pore-forming agents. Therefore, the CPOPT of Cap could be a safe, effective, stable, and promising preparation in the future.
Publisher
Maad Rayan Publishing Company
Reference17 articles.
1. An overview on various approaches to oral controlled drug delivery system via gastroretention;Surana AS;Int J Pharm Sci Rev Res,2010
2. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention
3. Progress in Controlled Gastroretentive Delivery Systems
4. Vyas SP, Khar RK. Controlled Drug Delivery Concepts and Advances: Osmotically Regulated Systems. 1st ed. Vallabh Prakashan; 2007. p. 477-801.
5. Aulton ME. Pharmaceutics the Science of Dosage form Design. 3rd ed. Churchill Livingstone; 2007. p. 460-1.